Follow
W. Riski Widya Mulyani
W. Riski Widya Mulyani
Fakultas Kedokteran Universitas Udayana
Verified email at student.unud.ac.id
Title
Cited by
Cited by
Year
Chaperone-Based Therapeutic Target Innovation: Heat Shock Protein 70 (HSP70) for Type 2 Diabetes Mellitus
WRW Mulyani, MID Sanjiwani, I Sandra, AAW Lestari, DM Wihandani, ...
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 13, 559, 2020
582020
New-onset diabetes in COVID-19: The molecular pathogenesis
DM Wihandani, MLA Purwanta, WRW Mulyani, IWAS Putra, ...
BioMedicine 13 (1), 3, 2023
32023
POTENSI ASAM FATTY OMEGA 3 DALAM PERLINDUNGAN RETINAL MELALUI GPR120/-ARRESTIN2 TANDA TANDA AKTIVASI PATHWAY SEBAGAI SEBUAH PREVENTIF INOVATIF DAN TERAPI KATATIF TERAPI …
KD Latifa, MID Sanjiwani, WRW Mulyani
1*
Potential of Omega 3 Fatty Acids in Retinal Protection Through GPR120/-arrestin2 Signaling Pathway Activation as an Innovative Preventive and Curative Therapy of Retinopathy …
KD Latifa, MID Sanjiwani, WRW Mulyani
Al-Iqra Medical Journal: Jurnal Berkala Ilmiah Kedokteran 3 (1), 42-59, 2019
2019
OP9-4: Diabetes Therapy and Abdominal Adiposity are Related with The Number of Gut Akkermansia muciniphila: A Study on Diabetic and Non-diabetic Balinese Population
MLA Purwanta, WRW Mulyani, YP Pinatih, KD Latifa, MR Saraswati
International Congress of Diabetes and Metabolism 2019, 47-47, 2019
2019
Plasmodium falciparum Serine Repeat Antigen 5 (PfSERA5): current vaccine candidate for Plasmodium falciparum malaria
A Bulaan, WRW Mulyani, AN Mahendra, IW Sumardika
The system can't perform the operation now. Try again later.
Articles 1–6